9 CRR-NY 4120.3NY-CRR
9 CRR-NY 4120.3
9 CRR-NY 4120.3
4120.3 Equine drug thresholds; per se
(a) A horse shall have raced in violation of this section if any of the following substances is found, by the laboratory conducting tests for the commission, to be present in a race-day urine or blood sample taken from such horse at a concentration in excess of a threshold listed below. The test result of such laboratory shall include an assessment of the measurement uncertainty and imprecision of the quantitative threshold for the substance.
(1) Acepromazine: 10 ng/ml HEPS in urine;
(2) Albuterol: 1 ng/ml in urine;
(3) Butorphanol:
(i) 300 ng/ml of total butorphanol in urine; or
(ii) 2 ng/ml of free butorphanol in plasma;
(4) Cetirizine: 6 ng/ml in plasma;
(5) Cimetidine: 400 ng/ml in plasma;
(6) Cobalt: 50 ng/ml in plasma;
(7) Dantrolene: 100 pg/ml of 5-hydroxydantrolene in plasma;
(8) Detomidine:
(i) 2 ng/ml of any metabolite of detomidine in urine; or
(ii) 1 ng/ml of detomidine in plasma;
(9) Diclofenac: 5 ng/ml in plasma;
(10) DMSO 10 mcg/ml in plasma;
(11) Firocoxib: 20 ng/ml in plasma;
(12) Flunixin: 20 ng/ml in plasma;
(13) Furosemide: 100 ng/ml in plasma and a specific gravity of urine less than 1.010;
(14) Glycopyrrolate: 3 pg/ml in plasma;
(15) Guaifenesin: 12 ng/ml in plasma;
(16) Ketoprofen: 2 ng/ml in plasma;
(17) Lidocaine: 20 pg/ml of total 3-hydroxylidocaine in plasma;
(18) Mepivacaine:
(i) 10 ng/ml of total hydroxymepivacaine in urine; or
(ii) any hydroxymepivacaine in plasma;
(19) Methocarbamol: 1 ng/ml in plasma;
(20) Methylprednisolone: 100 pg/ml in plasma;
(21) Omeprazole: 10 ng/ml of omeprazole sulfide in plasma;
(22) Phenylbutazone: 2 mcg/ml in plasma;
(23) Procaine penicillin: 25 ng/ml of procaine in plasma;
(24) Ranitdine: 40 ng/ml in plasma; and
(25) Xylazine: 200 pg/ml in plasma.
(b) A laboratory finding that a horse has not exceeded a threshold set forth in this section shall not constitute a defense to a violation of any other section of this Subchapter.
(c) A person who is found responsible for a violation of this section for the substance cobalt, when the detected concentration of cobalt exceeds 300 ng/ml in plasma, shall incur the same penalty described in section 4120.17(d)(2) of this Part.
9 CRR-NY 4120.3
Current through September 15, 2021
| End of Document |
IMPORTANT NOTE REGARDING CONTENT CURRENCY: The "Current through" date indicated immediately above is the date of the most recently produced official NYCRR supplement covering this rule section. For later updates to this section, if any, please: consult editions of the NYS Register published after this date; or contact the NYS Department of State Division of Administrative Rules at [email protected]. See Help for additional information on the currency of this unofficial version of NYS Rules.